Get alerts for new trials in your area by subscribing now
New
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
for
Urothelial Cancer, Bladder Cancer
Location: Nashville TN
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07129993
Phase2, Phase3, Recruiting
New
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: San Antonio TX
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07090499
Phase1, Recruiting
New
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
for
Non-Muscle Invasive Bladder Neoplasms
Location: Atlanta GA, Middleburg Heights OH, Germantown TN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06919965
Phase3, Recruiting
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
for
Bladder Cancer, Surgery
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT04979156
Recruiting
A Novel Multiplex ELISA Assay for Surveilling Patients with History of Bladder Cancer